Diffuse large B-cell lymphoma: open trials in Thailand

• NCT06091865

  A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma

  Trial Treatment · Phase 3 · Regeneron Pharmaceuticals

  Chulalongkorn University, Bangkok · Sriraj Hospital, Bangkok · Chaing Mai University, Chiang Mai · Faculty of Medicine, Khon Kaen

  Registry updated 2026-11-04

• NCT05139017

  A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

  Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC

  Faculty of Medicine Siriraj Hospital-Division of Hematology, Department of Medicine ( Site 0400), Bangkok · Maharaj Nakorn Chiang Mai Hospital ( Site 0401), Muang · Chulalongkorn University ( Site 0402), Pathumwan

  Registry updated 2026-11-03

• NCT06717347

  A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

  Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC

  Faculty of Medicine Siriraj Hospital ( Site 4001), Bangkoknoi · Maharaj Nakorn Chiang Mai Hospital ( Site 4002), Muang · Chulalongkorn University ( Site 4003), Pathumwan

  Registry updated 2026-10-21

All Diffuse large B-cell lymphoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error